Researchers have designed a molecule that targets short sequences of DNA that repeat many times, including those that cause the rare but fatal disease Friedreich’s ataxia.
Researchers have designed a molecule that targets short sequences of DNA that repeat many times, including those that cause the rare but fatal disease Friedreich’s ataxia.